Fertility Module #1: Fertility Care Considerations: Introduction to Infertility for the Specialty Health Care Pharmacist

Module 1 reviews the physiology of reproduction and the effects of hormone regulation. Also discussed are risk factors for infertility, diagnostic tests used in identifying infertility, and types of assisted reproductive technology. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #2: Infertility: Therapeutics and Medication Profiles

Module 2 will review the mechanism of action of the typical agents used to affect infertility. Medication adverse effects, administration, storage, and other information regarding these agents will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #3: Infertility: Protocols and Patient Management

Module 3 reviews the appropriate pharmacological and non-pharmacological protocols typically used to address infertility. Available for free to NASP members. Visit www.ProCE.com/CSPE

Fertility Module #4: Fertility Care Considerations: Infertility: Special Populations and Considerations

Module 4 will conclude with addressing some of the special considerations in patients with infertility issues. The role of the specialty pharmacy and the pharmacy care plan along with issues of adherence will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE

Going Forward in Reverse: Navigating Treatment for Acute Major Bleeding

The goal of this educational activity is to enhance the pharmacist’s knowledge of the impact of acute major bleeding and patient assessment and management options.

Hemophilia in Specialty Pharmacy

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #1: The abCs of HCV

Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #3: HCV Drug Therapy Management

Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed. This activity is available for free to NASP members. Visit the top section of www.ProCE.com/CSPE for details.